Provided by Tiger Fintech (Singapore) Pte. Ltd.

Invivyd, Inc.

0.7323
+0.03835.52%
Post-market: 0.73230.00000.00%19:32 EDT
Volume:824.00K
Turnover:592.03K
Market Cap:87.85M
PE:-0.61
High:0.7388
Open:0.7020
Low:0.6900
Close:0.6940
Loading ...

Invivyd forms SPEAR study group to assess therapy for long-COVID

TIPRANKS
·
02 Jul

Invivyd Inc. Launches SPEAR Study Group to Explore Monoclonal Antibody Therapy for Long COVID and Post-Vaccination Syndrome

Reuters
·
02 Jul

Invivyd Is Maintained at Buy by D. Boral Capital

Dow Jones
·
26 Jun

Invivyd Says Study Shows VYD2311 Well Tolerated as COVID-19 Drug Candidate

MT Newswires Live
·
26 Jun

Invivyd announces full Phase 1/2 clinical data for VYD2311

TIPRANKS
·
26 Jun

BRIEF-Invivyd Announces Positive Full Phase 1/2 Clinical Data For Vyd2311

Reuters
·
26 Jun

Invivyd Inc. Announces Upcoming FDA Meeting in Early Q3 to Discuss Regulatory Pathways for VYD2311 COVID-19 Monoclonal Antibodies

Reuters
·
26 Jun

Invivyd Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
29 May

Invivyd price target lowered to $5 from $10 at H.C. Wainwright

TIPRANKS
·
28 May

Invivyd announces results from CANOPY Phase 3 trial

TIPRANKS
·
27 May

Invivyd's Pemgarda Added to NCCN Guidelines in Oncology for B-Cell Lymphomas

MT Newswires Live
·
23 May

Invivyd Inc. Engages FDA for Expedited Pathway on COVID-19 Monoclonal Antibody Development Amidst Regulatory Review

Reuters
·
21 May

Invivyd Is Maintained at Buy by D. Boral Capital

Dow Jones
·
17 May

Invivyd Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Invivyd Q1 EPS $(0.14) Up From $(0.38) YoY, Sales $11.30M Up from 0 YoY

Benzinga
·
15 May

Invivyd Inc. Reports Q1 2025 Results: PEMGARDA Revenue at $11.3M, Net Loss Reduced to $16.3M, EPS at $0.14

Reuters
·
15 May

BRIEF-Invivyd Q1 EPS USD -0.14

Reuters
·
15 May

Invivyd Urges US FDA to Focus on Monoclonal Antibodies for COVID-19 Prevention, Re-Assess Vaccine Efficacy

MT Newswires Live
·
14 May

Invivyd Inc expected to post a loss of 3 cents a share - Earnings Preview

Reuters
·
13 May

BUZZ-U.S. STOCKS ON THE MOVE-Hims & Hers Health, TXNM Energy, Forge Global

Reuters
·
13 May